Fomivirsen: Clinical Pharmacology and Potential Drug Interactions

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.41, Iss.4, 2002-01, pp. : 255-260

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fomivirsen

By Perry C.M. Barman Balfour J.A.

Drugs, Vol. 57, Iss. 3, 1999-03 ,pp. : 375-380

Adis International

Access to resources Recommend Favorite

Clinical pharmacology in drug development — an update

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 4, 2015-07 ,pp. : 243-244

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is pomegranate juice a potential perpetrator of clinical drug–drug interactions? Review of the in vitro, preclinical and clinical evidence

By Srinivas Nuggehally

European Journal of Drug Metabolism and Pharmacokinetics, Vol. 38, Iss. 4, 2013-12 ,pp. : 223-229

Springer Publishing Company

Access to resources Recommend Favorite

Maraviroc potential drug-drug interactions

Reactions Weekly, Vol. 1, Iss. 1207, 2008-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Drug-drug interactions involving lysosomes: mechanisms and potential clinical implications

By Logan Randall Funk Ryan S Axcell Erick Krise Jeffrey P

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 8, 2012-08 ,pp. : 943-958

Informa Healthcare

Access to resources Recommend Favorite